title: Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy.
abstract: We describe 2 pediatric patients with sickle cell disease (SCD) who developed seropositive juvenile rheumatoid arthritis (JRA). Both patients have severe joint damage, the compound effect of both disease processes. The bone and cartilage destruction, which poses serious therapeutic challenges, highlights the difficulty of making a diagnosis of chronic inflammatory disease in the setting of SCD. There may be a correlation between increased levels of tumor necrosis factor-alpha in the synovial tissue of joints damaged by arthritis and local sickling. The resultant ischemia and corresponding inflammatory infiltrates could in turn worsen existing synovial proliferation and cartilage destruction as well as trigger further sickling.
authors.affiliation: Paediatric Rheumatology Unit, Great Ormond Street Hospital, London, England.
authors.forename: K
authors.initials: K
authors.lastname: Nistala
authors.forename: K J
authors.initials: KJ
authors.lastname: Murray
mesh_terms: D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D001171:Arthritis, Juvenile / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage; D026741:Physical Therapy Modalities; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D007052:Ibuprofen; D008727:Methotrexate